pharmaceuticals | Science and Enterprise

Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were high… https://t.co/oLdLmHGz1M
about 18 hours ago
New post on Science and Enterprise: Venture Funds, Mergers in A.I. Up Sharply in 2018 https://t.co/rimak87tjS #Science #Business
about 18 hours ago
Wish it weren't needed, but ... https://t.co/SZAb2GO2vz
about 3 days ago
The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness… https://t.co/XaxxGJOYQl
about 3 days ago
New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use https://t.co/cvVj3IyCR0 #Science #Business
about 3 days ago

Anti-Inflammatory Human Protein Produced in Plants

By Alan, on February 27th, 2019%

Researchers in Canada genetically engineered tobacco plants to economically produce large quantities of a human protein with anti-inflammatory properties. . . . → Read More: Anti-Inflammatory Human Protein Produced in Plants

Trials Underway Testing Crispr for Blood Disorders

By Alan, on February 27th, 2019%

Clinical trials testing the genome editing technique Crispr for sickle cell disease and beta thalassemia, two inherited blood disorders, enrolled and infused their first patients. . . . → Read More: Trials Underway Testing Crispr for Blood Disorders

Gene Editing Deactivates Cause of T-Cell Side Effects

By Alan, on February 26th, 2019%

A biotechnology company developing engineered T-cells as treatments for cancer, used gene editing to deactivate a likely cause of serious adverse effects from its therapies. . . . → Read More: Gene Editing Deactivates Cause of T-Cell Side Effects

Organoids Designed for Faster Cancer Diagnostics

By Alan, on February 26th, 2019%

A new process grows small samples of tumor tissue in the lab to enable high-speed diagnostics for personalized cancer treatments and drug testing. . . . → Read More: Organoids Designed for Faster Cancer Diagnostics

Gene Therapy Company Acquired in $4.3B Deal

By Alan, on February 25th, 2019%

Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion. . . . → Read More: Gene Therapy Company Acquired in $4.3B Deal

Start-Up Raises $10.5M for Precision Immunotherapies

By Alan, on February 21st, 2019%

A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round. . . . → Read More: Start-Up Raises $10.5M for Precision Immunotherapies

Targeted Chemo Seen Benefiting Breast Cancer Patients

By Alan, on February 21st, 2019%

A clinical trial shows a treatment combining an antibody and chemotherapy drug invokes a response and longer survival time in many patients with metastatic triple-negative breast cancer. . . . → Read More: Targeted Chemo Seen Benefiting Breast Cancer Patients

Trial Shows RNA Therapy Safe for Diabetes

By Alan, on February 20th, 2019%

Results from a clinical trial show a new drug with synthetic messenger RNA is safe for people with diabetes, and has the potential to promote new blood vessel growth. . . . → Read More: Trial Shows RNA Therapy Safe for Diabetes

High-Speed Screens, A.I., Boost Nanoscale Medicines

By Alan, on February 20th, 2019%

Biomedical engineers are using high-throughput screening techniques and machine learning to speed and improve the design of new drugs based on nanoscale particles. . . . → Read More: High-Speed Screens, A.I., Boost Nanoscale Medicines

Stem Cell Genes Edited to Avoid Immune Rejection

By Alan, on February 19th, 2019%

A new study shows editing the genomes of adult stem cells can avoid their rejection by the immune system when implanted in lab mice other than the stem cell donor. . . . → Read More: Stem Cell Genes Edited to Avoid Immune Rejection

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise